Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Dodoo, Alexander N O ^a   Fogg, Carole ^b,c   Asiimwe, Alex ^c   Nartey, Edmund T ^a   Kodua, Augustina ^a   Tenkorang, Ofori ^a   Ofori Adjei, David ^a  

^a UNIVERSITY OF GHANA   (Ghana)

^b DRUG SAFETY RESEARCH UNIT   (United Kingdom)

^c UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANALGESIC AGENT; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; DIHYDROARTEMISININ; FANSIDAR; METAKELFIN; PYRIMETHAMINE; QUININE; SULFALENE; ARTEMISININ DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; FEMALE; GHANA; HEALTH CARE FACILITY; HEALTH CARE POLICY; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; OUTPATIENT; PHARMACY; PRESCRIPTION; URBAN AREA; AGED; ANIMAL; CLINICAL PRACTICE; DRUG COMBINATION; DRUG EFFECT; DRUG LEGISLATION; GROWTH, DEVELOPMENT AND AGING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARASITOLOGY; PLASMODIUM; PRESCHOOL CHILD; PROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GHANA; HUMANS; LEGISLATION, DRUG; LOGISTIC MODELS; MALARIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PLASMODIUM; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 61849183560     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-2     Document Type: Article

References (21)

1. Malaria disaster in Africa. K Marsh, Lancet 1998 352 924 10.1016/S0140-6736(05)61510-3 9752813
2. Averting a malaria disaster. NJ White F Nosten S Looareesuwan WM Watkins K Marsh RW Snow G Kokwaro J Ouma TT Hien ME Molyneux TE Taylor CI Newbold TK Ruebush 2nd M Danis BM Greenwood RM Anderson P Olliaro, Lancet 1999 353 1965 7 10.1016/S0140-6736(98)07367-X 10371589
3. Malaria Research Programme of the Medical Research Council SA. http://www.malaria.org.za/Malaria-Risk/Update/update2005.html
4. World Health Organization. Global AMP Database - AFRO. http://www.who.int/malaria/amdp/amdp-afro.htm
5. Ghana Health Service, Ghana National Antimalarial Policy. Accra 2004
6. Stop sale: Ministry orders withdrawal of two brands of new malarial drugs. EK Yeboah, Daily Graphic
7. Benefits of spontaneous reporting ADR systems to public health programmes in Sub-Saharan Africa. ANO Dodoo C Bart-Plange NK Allotey S Segbeya A Appiah-Danquah J Nyarko, Drug Safety 2007 30 931 932 10.2165/00002018-200730040- 00007
8. Prescription-event monitoring - recent progress and future horizons. RD Mann, Br J Clin Pharmacol 1998 46 195 201 9764958 10.1046/j.1365-2125.1998. 00774.x
9. Signal generation in the New Zealand Intensive Medicines Monitoring Programme: a combined clinical and statistical approach. DM Coulter, Drug Safety 2002 25 433 9 10.2165/00002018-200225060-00007 12071780
10. World Health Organization, Facts on ACTs (Artemisinin-based combination therapies). Geneva 2006
11. World Health Organization, Review of the safety of chlorproguanil-dapsone in the treatment of uncomplicated falciparum malaria in Africa: Report of a Technical Consultation convened by the World Health Organization. Geneva 2005
12. Urban malaria and anaemia in children: a cross-sectional survey in two cities of Ghana. E Klinkenberg PJ McCall MD Wilson AO Akoto FP Amerasinghe I Bates FH Verhoeff G Barnish MJ Donnelly, Trop Med Int Health 2006 11 578 88 10.1111/j.1365-3156.2006.01609.x 16640609
13. Sample size considerations for pharmacoepidemiology studies. B Strom, Pharmacoepidemiology Chichester, UK: John Wiley & Sons, Strom B, 4 2005 29 36
14. D Hosmer S Lemeshow, Applied Logistic Regression NY: Wiley & Sons 2 2000
15. Improved diagnostic testing and malaria treatment practices in Zambia. DH Hamer M Ndhlovu D Zurovac M Fox K Yeboah-Antwi P Chanda N Sipilinyambe JL Simon RW Snow, JAMA 2007 297 2227 31 10.1001/jama.297.20.2227 17519412
16. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). C Wongsrichanalai MJ Barcus S Muth A Sutamihardja WH Wernsdorfer, Am J Trop Med Hyg 2007 77 6 Suppl 119 127 18165483
17. World Health Organization, UNICEF, Improving child health IMCI 1999
18. The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. H Reyburn J Ruanda O Mwerinde C Drakeley, Malar J 2006 5 4 16423307 10.1186/1475-2875-5-4
19. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. D Zurovac M Ndhlovu AK Rowe DH Hamer DM Thea RW Snow, BMJ 2005 331 734 16195289 10.1136/bmj.331.7519. 734
20. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice 2008: an early experience from Kenya. D Zurovac J Njogu W Akhwale DH Hamer RW Snow, Trop Med Int Health 2008 13 99 107 18291008
21. Bill and Melinda Gates Foundation. http://www.gatesfoundation.org/ speeches-commentary/Pages/bill-gates-malaria-forum.aspx